Safety of Ultra-rush Schedule of Subcutaneous Allergen Immunotherapy With House Dust Mite Extract Conducted in an Outpatient Clinic in Patients With Atopic Dermatitis and Allergic Rhinitis

So-Hee LEE; Myoung-Eun KIM; Yoo-Seob SHIN; Young-Min YE; Hae-Sim PARK; Dong-Ho NAHM.
Allergy, Asthma & Immunology Research ; : 846-855, 2019.
Artículo en Inglés | WPRIM | ID: wpr-762166

Documentos relacionados

  1. [OBJECTIVE EVALUATION OF SUBLINGUAL IMMUNOTHERAPY FOR PEDIATRIC ALLERGIC RHINITIS RESPOND TO SQ HOUSE DUST MITE].
  2. The relationship of <i>D. pteronyssinus</i> allergic component sIgE and sIgG4 in house dust mite allergic rhinitis or/and allergic asthma patients.
  3. Allergen Differences and Correlation Analysis in Siblings Diagnosed with Respiratory Allergic Diseases.
  4. Clinical Efficacy and Possible Mechanism of Endoscopic Vidian Neurectomy for House Dust Mite-Sensitive Allergic Rhinitis.
  5. Clinical characteristics of local allergic rhinitis sensitized to house dust mites in Asia.
  6. Interaction of the TLR4 rs1927911 polymorphism with house dust mite sensitization in allergic rhinitis with its prognosis.
  7. Clinical effectiveness of house dust mite immunotherapy in mono- versus poly-sensitised patients with allergic rhinitis: a systematic review and meta-analysis.
  8. Diagnostic Performance of IgE Anti-Der p 10 to Identify Patients with Shrimp Allergy.
  9. Which patients with asthma are most likely to benefit from allergen immunotherapy?
  10. Comparison of rush-subcutaneous and sublingual immunotherapy with house dust mite extract for pediatric allergic rhinitis: A prospective cohort study.